Cannabis Law Report

AUGUST 8, 2021

Advocacy group TheraPsil is teaming up with lawyers to pressure the government to grant access and develop regulations. More than ever, Canadians want to use psychedelics as medicine to relieve severe mental distress, but after a promising stretch of granted exemptions, regulator Health Canada appears to be stalling the process.

Access 105

Access Patients Legalization Advocacy 105

Cannabis Law Report

AUGUST 20, 2021

The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. Many are finding that despite the treatment being approved, they are being denied access in their area.”.

Access 105

Access Patients Media Treatment 105

Cannabis Law Report

DECEMBER 11, 2021

A Manchester MP’s bid to open up cannabis treatments on the NHS has been blocked by Tory backbenchers in the House of Commons. 'A Despite the Government legalising medicinal cannabis in 2018, following a number of high-profile campaigns, thousands of people are still being denied access to the treatment.

Treatment 52

Treatment Access Patients Medicine 52

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients registered with the state’s Department of Public Health can purchase cannabis oil from Georgia’s independent pharmacies.

Oil 98

Oil Patients Access THC 98

NORML

JUNE 1, 2020

House and Senate lawmakers have approved a series of bills to facilitate patients’ access to medical cannabis products. ” Under the current law, doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. .” John Bel Edwards.

Access 184

Access Therapy Legislation Patients 184

United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments. Could marijuana be the answer?

Treatment 122

Treatment Cannabinoids Blood Pressure THC 122

MGC Pharma

FEBRUARY 15, 2018

What will unrestricted access to Medicinal Cannabis look like in Australia? A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. kg of CBD and 163.7

Access 100

Access Medicine Chronic Pain Research and Development 100

MMJ Recs

MARCH 28, 2024

Navigating the world of medical marijuana (MMJ) in Iowa can be a daunting task for patients seeking alternative treatments. From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey.

Patients 52

Patients Treatment Research and Development Therapy 52

Cannabis Law Report

JULY 28, 2021

Cannabis Patient Care™ launched in November 2020 and has already made a big impression in the medical cannabis community due to the quality of its content and the important message behind each issue,” said Mike Hennessy Jr.

Access 105

Access Patients Education Treatment 105

MMJ Recs

JANUARY 10, 2024

Benefits of Medical Marijuana for Pain Relief The medicinal properties of marijuana, particularly its cannabinoids, have been harnessed for centuries. Medical marijuana is increasingly recognized for its ability to offer relief in conditions such as neuropathic pain, arthritis, and pain associated with certain medical treatments.

Chronic Pain 98

Chronic Pain Patients Cannabinoids Treatment 98

Veriheal

MAY 30, 2023

But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. in cancer patients undergoing anticancer treatment, 50.7%

Medicine 98

Medicine Treatment Patients Data 98

NORML

NOVEMBER 8, 2019

This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. Once enacted, veterans will be able to access medical marijuana treatment without the added challenge of accessing a private, non-VA physician.

Access 209

Access Marijuana Treatment Legislation 209

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 252

Clinical Trials Chronic Pain Cannabinoids Patients 252

MMJ Recs

JANUARY 16, 2023

West Virginia pain treatment is very effective at treating a range of chronic pain conditions. Pain management doctors in West Virginia use a variety of treatments, including medical marijuana , to treat chronic pain. Read on to discover some of the best pain management centers in West Virginia that MMJ patients should know about.

Chronic Pain 98

Chronic Pain Patients Treatment Medicine 98

NORML

FEBRUARY 13, 2019

Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.

Legislation 235

Legislation Access Chronic Pain Marijuana 235

Cannabis Law Report

SEPTEMBER 28, 2021

“Ryan’s Law” will expand end-of-life treatment and pain relief options for Californians. It is inconceivable to me that, in a state where medical cannabis was legalized more than 25 years ago, those in deepest suffering receiving treatment in our state’s healthcare facilities cannot access this proven, effective, and prescribed treatment,”.

Patients 98

Patients Access Law Treatment 98

Cannabis Law Report

JANUARY 11, 2022

Legal cannabis partnership to help patient access. The new distributor in the Australian medicinal cannabis industry – The Entourage Effect – has signed a firstof its kind deal with innovative medical cannabis clinic MiDispensary. As part of the partnership, The Entourage Effect will sell exclusively to patients of MiDispensary.

Access 52

Access Patients Clinical Trials Legalization 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

MMJ Recs

OCTOBER 18, 2023

With a growing number of New Jersey MMJ dispensaries offering a wide range of cannabis products, it’s essential for MMJ patients to stay informed about the options available. Patients can now access a wide variety of cannabis products to address their medical needs. They offer a variety of strains and product options.

Dispensary 98

Dispensary Patients Education Strains 98

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

MMJ Recs

OCTOBER 31, 2023

The Mountain State’s journey to legalizing medical marijuana has been a transformative one, and it marks a new era for MMJ access in West Virginia. This act has opened the doors to legal MMJ access for eligible patients, offering an alternative approach to managing their health.

Access 52

Access Programs Patients Dispensary 52

NewsMunchies

JULY 10, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions. Using AI-powered medicine could allow for more effective treatment of conditions such as heart disease, cancer, and cystic fibrosis.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. It is not a story about profiting off of people.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Chronicles

MAY 22, 2019

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”.

Medicine 140

Medicine Research and Development Data Collective 140

MMJ Recs

OCTOBER 13, 2023

For patients seeking access to this valuable form of treatment, it’s essential to understand the complex web of regulations, legal requirements, and rights surrounding medical marijuana in the Golden State. This recommendation is a critical legal document that allows patients to use and possess medical marijuana.

Patients 52

Patients Law Cultivation Dispensary 52

Cannabis Law Report

APRIL 4, 2022

Congress, signed into law by President Trump, with 41 state enactments, give terminally ill patients access to experimental medicines still in development? But the Drug Enforcement Agency is barring access to one such experimental medicine: psilocybin, also known in its fungal form as “magic mushrooms.”.

Access 52

Access Patients DEA Research and Development 52

Cannabis Law Report

FEBRUARY 14, 2022

Our families and communities are suffering, and we urgently need access to preventative and curative medicines and medical care that is safe and effective. These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine.

Medicine 52

Medicine Access Therapy Treatment 52

Veriheal

AUGUST 15, 2022

In their recently published study, titled “The Effects of Consuming Cannabis Flower for Treatment of Fatigue,” the UNM researchers proved that the Cannabis sativa plant instantly reduced feelings of fatigue in most consumers. The sessions were logged by a total of 1,224 people who had access to the app.

Treatment 96

Treatment Research and Development Sativa Cannabinoids 96

Veriheal

JUNE 22, 2023

The judge responded by stating that anxiety was not a sufficient reason to use medical marijuana and ordered the defendant to stop using cannabis medicinally as part of her probation. That way, patients in genuine need of relief can access appropriate treatment options without fear of being turned away or discriminated against.

Patients 75

Patients Treatment Conditions Cannabis 75

Cannabis Law Report

FEBRUARY 24, 2022

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. Timeline of Medicinal Legalization in Canada. 01.015 of the FDR before providing the new drug to a patient.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Veriheal

JUNE 21, 2023

There will also be measures put in place to control therapeutic access to psilocybin while awaiting federal reform. If approved by the Food and Drug Administration (FDA), this psychedelic would be used to treat chronic and life-threatening mental disorders, especially for patients with limited access to effective treatments.

Access 97

Access Legalization Research and Development Legislation 97

Veriheal

JUNE 20, 2023

Depression and addiction continue to impact millions of lives worldwide, making the search for effective treatments crucial. In a recent 2023 study , scientists have developed two promising drug candidates for treating these conditions, drawing inspiration from a traditional African psychedelic plant medicine called ibogaine.

Medicine 98

Medicine Research and Development Treatment Conditions 98

Cannabis Law Report

JUNE 21, 2021

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Office of Medicinal Cannabis, Department of Health, Melbourne, VIC 3000, Australia.

Medicine 59

Medicine Safety Policy Treatment 59

The Cannigma

MARCH 25, 2021

In nursing school, I wrote my dissertation on the role of the nurse when caring for patients using cannabis therapeutically, knowing that nurses are often the first healthcare professional to whom patients disclose their cannabis use. I remain in awe of these patients to this day. The goals of our organization are simple.

Patients 145

Patients Clinical Trials Medicine Events 145

MMJ Recs

DECEMBER 13, 2023

While the state has traditionally held a conservative stance on cannabis, there has been a gradual shift in public opinion and legislative action, paving the way for a more inclusive and patient-centric approach to healthcare. Additionally, patients must have exhausted all other available treatment options without finding relief.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

Veriheal

MAY 26, 2022

But one area of cannabis medicine is still lagging behind—research. Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. RoC also works to increase patients’ access to medical cannabis by helping U.S.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98